Mani Sharma insider trades: Astrazeneca (AZN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mani reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 8, 2026 | AZN | ↑ Buy | 20 | $160.57 | $3K | Direct | Sep 11, 2026 (34d) |
| May 20, 2026 | AZN | ↓ Sell | 11,893 | $185.78 | $2.2M | Direct | May 22, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mani Sharma's insider trades
Mani Sharma is See remarks at Astrazeneca (AZN). Since May 20, 2026, Mani has reported 1 open-market purchase worth $3K and 1 sale worth $2.2M on SEC Form 4. In the last 12 months: 1 buy ($3K) and 1 sale ($2.2M).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AZN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.